ALK‐ and EGFR‐positive NSCLCs have distinct histological profiles,15, 16, 17 suggesting that their tumor marker profiles may also be different; however, no study to date has compared the tumor marker profile of NSCLCs with different driver gene mutations. The gene discussed is ALK; the disease is neoplasm.